51144-19-5

Basic information

• Product Name: 2(1H)-Quinoxalinone,3-methyl-,hydrazone(9CI)
• Synonyms: 2(1H)-Quinoxalinone,3-methyl-,hydrazone(9CI);2-hydrazinyl-3-methylquinoxaline
• CAS NO: 51144-19-5
• Molecular Formula: C₉H₁₀N₄
• Molecular Weight: 174.2
• Product Categories: PIPERIDINE
• Mol File: 51144-19-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2(1H)-Quinoxalinone,3-methyl-,hydrazone(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2(1H)-Quinoxalinone,3-methyl-,hydrazone(9CI)(51144-19-5)
• EPA Substance Registry System: 2(1H)-Quinoxalinone,3-methyl-,hydrazone(9CI)(51144-19-5)

Safety Data

• Hazardous Substances Data: 51144-19-5(Hazardous Substances Data)

Usage

Structure

Hydrazone derivative of 3-methyl-2(1H)-quinoxalinone

Classification

Quinoxalinone compound

Potential applications

Pharmaceutical research and drug development

Biological activity

Unique

Need for further research

To fully understand properties and potential uses

Upstream product

• 32601-86-8 2-chloro-3-methylquinoxaline 
• 14003-34-0 3-methyl-2-oxo-1,2-dihydroquinoxaline 
• 95-54-5 1,2-diamino-benzene 
• 14003-34-0 3-methylquinoxalin-2-ol 

Downstream Products

• 198709-45-4 2-(3-Methyl-quinoxalin-2-yl)-5-phenyl-2H-pyrazol-3-ylamine 
• 198709-51-2 2-(3-Methyl-quinoxalin-2-yl)-5-p-tolyl-2H-pyrazol-3-ylamine 
• 198709-49-8 5-(4-Chloro-phenyl)-2-(3-methyl-quinoxalin-2-yl)-2H-pyrazol-3-ylamine 
• 198709-47-6 5-(4-Bromo-phenyl)-2-(3-methyl-quinoxalin-2-yl)-2H-pyrazol-3-ylamine 
• 1159992-25-2 1-(4-methoxyphenyl)-4-methyl-1,2-dihydro[1,2,4,3]triazaphospholo[4,5-a]quinoxaline-1-sulfide 
• 1350322-13-2 1-(2-chlorophenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline 
• 19848-92-1 4-methyl-1-phenyl-[1,2,4]triazolo[4,3-a]quinoxaline 
• 1427029-25-1 1-(4-chloro-benzyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline 
• 1350322-14-3 1-(2-nitrophenyl)-4-methyl-1,2,4-triazolo[4,3-a]quinoxaline 
• 1350322-11-0 2-(N'-(1,3-diphenyl-1H-pyrazol-4-ylmethylidene)hydrazino)-3-methylquinoxaline 
• 1350322-16-5 1-(1,3-diphenyl-1H-pyrazol-4-yl)-4-methyl-1,2,4-triazolo[4,3-a]quinoxaline 
• 1146978-41-7 1-(4-fluorophenyl)-4-methyl-1,2,4-triazolo[4,3-a]quinoxaline 
• 1350322-17-6 1-(3-methyl-1-(p-nitrophenyl)-1H-pyrazol-4-yl)-4-methyl-1,2,4-triazolo[4,3-a]quinoxaline 
• 1350322-12-1 2-[N'-((3-methyl-1-(p-nitrophenyl)-1H-pyrazol-4-yl)methylidene)hydrazino]-3-methylquinoxaline 

Relevant articles and documents

TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS

The present invention is directed to triazolopyrazine compounds of Formula (I). Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds as therapeutic agents treating neurological and psychiatric disorders.

Potential virostatics. 1. Quinoxalines

-